This course is available to watch on-demand. There is no CME associated with this program.
ATA’s Year in Thyroidology: A Virtual Experience
This event is designed to provide you with succinct updates on the latest research and clinical care. Our esteemed speakers from around the world will share their insight with event attendees and participate in interactive questions and answers with attendees.
Included in this webinar:
Sessions from Friday, February 19, 2021
This session highlights new therapeutics and treatment strategies for advanced thyroid cancer including discussions on RET-altered thyroid cancers, targeted treatment strategies for advanced thyroid cancer and an overview of the recently published paper “Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.”
This session explores immunomodulators, immunotherapies, and their effects on the thyroid gland, specifically immunotherapy and thyroid cancer and how D-L1 inhibitor induced thyroiditis is associated with better overall survival in cancer patients.
This session explores hypothyroidism and combination therapy and highlights the recent consensus statement from ATA, ETA and BTA.
Join two leaders in the field to discuss the current status of active surveillance in the US.
ATA has several guidelines under development. This session will highlight the topics that will be covered in the forthcoming Differentiated Thyroid Cancer and Nodules Guidelines.
Sessions from Saturday, February 20, 2021
Artificial intelligence holds great promise in identifying and treating thyroid nodules. This session looks at how artificial intelligence can be used in nodule risk assessment and explore what’s next in the evolution of how we categorize nodules.
This session explores non-surgical treatment of benign nodules including ethanol ablation of Cystic nodules, the RFA Experience in S. Korea, and laser ablation for thyroid nodules.
This session delves into novel treatment strategies for Graves’ Disease and highlights recent advances in treating of Graves’ Ophthalmopathy.
Join two leaders in the field to explore progress and challenges in caring for thyroid nodules.
Join two leaders in the field to discuss hot topics in thyroid surgery for 2021.
Please wait ...